Nephrologist Nudge Study: Glycemic and Lipid Management in Glomerulonephritis

Supplementary Material for 'Nudging nephrologists in cardiovascular risk assessment and management in glomerular diseases treated with immunosuppressants' presents data from a single-center implementation study. The dataset includes 192 patients (median age 58) with 859 clinical visits, comparing the prevalence of glycemic and lipid evaluations before and after an EMR-based physician prompt intervention from July 2022 to June 2024. It likely contains patient demographics, visit details, and outcomes related to the intervention's impact on clinical management.

Use Cases

• Evaluating the effectiveness of EMR-based physician prompts on clinical guideline adherence using pre-post visit data.
• Analyzing factors associated with glycemic evaluation in older patients with glomerulonephritis based on adjusted regression models.
• Studying the prevalence of specific glomerulonephritis subtypes (e.g., lupus nephritis, IgA nephropathy) in a clinical cohort.
• Benchmarking rates of cardiovascular risk factor screening in a specialty nephrology clinic setting.

Strengths

• Dataset is derived from a structured clinical study with a clear pre-post design, involving 192 patients and 859 visits.
• Provides specific, quantified results on intervention impact, such as the odds ratio (OR 2.38) for increased glycemic evaluation.
• Includes detailed patient cohort characteristics, including median age (58) and breakdown of glomerulonephritis causes (e.g., 26.9% lupus nephritis).

Limitations

• Column names and the full data schema are not provided in the source metadata, limiting understanding of the data structure.
• The dataset represents a single-center study, which may limit generalizability of findings.
• The file format is listed only as DOCX, which may not be ideal for direct computational analysis compared to structured formats like CSV.

Provenance

Source

figshare admin karger

Collection Method

Data were obtained from electronic medical records (EMR) at 6-monthly intervals for a clinical implementation study.

Time Range

July 2022 to June 2024

Freshness

Last updated on 2026-03-23.